GO
Loading...

Acquisitions

More

  • Sept 25- Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.

  • DirecTV shareholders approve $48.5B sale to AT&T Thursday, 25 Sep 2014 | 11:59 AM ET

    NEW YORK— AT&T's proposed $48.5 billion acquisition of DirecTV is moving forward as shareholders of the country's largest satellite TV broadcaster approved the deal. Public-interest groups say the deal would lead to less competition, since AT&T and DirecTV provide pay-TV services to about 25 percent of the country. DirecTV has 20 million subscribers.

  • LabCorp to buy LipoScience for $85.3M in cash Thursday, 25 Sep 2014 | 9:47 AM ET

    BURLINGTON, N.C.— Laboratory Corp. of America will pay $85.3 million in cash for diagnostic test maker LipoScience Inc. in a deal that aims to strengthen its clinical decision support programs. LabCorp will pay $5.25 for each LipoScience share, a 65 percent premium to the stock's closing price on Wednesday.

  • Valeant pitches potential eye drug, research focus Thursday, 25 Sep 2014 | 8:28 AM ET

    Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.

  • Valeant Pharma expects 3Q revenue to top forecasts Wednesday, 24 Sep 2014 | 11:59 AM ET

    Allergan has rebuffed several takeover bids from Valeant over the past few months, the latest amounting to about $53 billion. That could give Valeant and activist investor Bill Ackman's Pershing Square Capital Management LP, which has built a large stake in Allergan, a chance at a takeover.

  • The United States and Arab allies bombed Syria for the first time on Tuesday, killing scores of Islamic State fighters and members of a separate al Qaeda- linked group, opening a new front against militants by joining Syria's three-year-old civil war. AbbVie has agreed to a deal to acquire Shire, which fell 1.9 percent to $251.38 in New York.

  • SAO PAULO, Sept 23- Grupo Oi SA, Brazil's most indebted telecom company, backed out of a key auction for fourth-generation cell spectrum on Tuesday, adding to speculation of an upcoming takeover in a highly competitive wireless market.

  • SEC alleges insider trading in coal acquisition Tuesday, 23 Sep 2014 | 11:28 AM ET

    CHARLESTON, W.Va.— Federal regulators claim that three men used insider information to profit illegally from Arch Coal's acquisition of International Coal Group. Frank Tamayo schemed with two other men to generate more than $5.6 million in profits from 13 mergers and acquisitions, the U.S. Securities and Exchange Commission says in a lawsuit.

  • TTM Technologies buying competitor Tuesday, 23 Sep 2014 | 10:29 AM ET

    The acquisition of Viasystems Group, Inc., of St. Louis, Missouri, is expected to be completed during the first half of 2015 would give TTM 30,000 employees in 10 assembly factories in the U.S., Canada and China. TTM says the acquisition of Viasystems will diversify its business partners and provide entry into the automotive industry.

  • *May deter Pfizer from returning to bid for AstraZeneca. LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. The move could jeopardize an agreed deal for AbbVie to buy Shire for $55 billion and deter Pfizer from making another attempt to acquire AstraZeneca, after a $118 billion takeover attempt failed in May.

  • LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire both fell more than 5 percent on Tuesday after the U.S. The move appears to jeopardise an agreed deal for AbbVie to buy Shire for $55 billion and could deter Pfizer from making another attempt to acquire AstraZeneca, after a $118 billion takeover attempt failed in May.

  • US cracks down on companies moving overseas Monday, 22 Sep 2014 | 4:47 PM ET

    Administration officials who briefed reporters could not say how many pending inversions might be stopped by the new rules and specifically would not address whether the rules would block one of the most high-profile moves, an effort that Burger King announced in August to acquire Tim Hortons, a Canadian coffee and doughnut chain.

  • MGM moves into TV     Monday, 22 Sep 2014 | 1:11 PM ET

    CNBC's Julia Boorstin MGM has acquired a 55 percent stake in two Mark Burnett firms.

  • NEW YORK, Sept 22- Private equity firm Silver Lake is in advanced talks to acquire online photo-sharing service Shutterfly Inc for at least $2 billion, people familiar with the matter said on Monday. Silver Lake has outbid other buyout firms in an auction for Shutterfly and is now negotiating the terms of an acquisition, the sources said.

  • FRANKFURT, Sept 22- Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history.

  • Sept 22- Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's $2.2 billion takeover offer "significantly undervalues" the company, but left the door open for talks on a possible deal.

  • FRANKFURT, Sept 22- Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S. company Sigma-Aldrich for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history.

  • TTM to buy rival circuit board maker Viasystems Monday, 22 Sep 2014 | 8:48 AM ET

    NEW YORK— TTM Technologies Inc. said Monday that it plans to buy rival circuit board maker Viasystems Group Inc. for about $368 million in cash and stock. Costa Mesa, California- based TTM is paying $11.33 in cash and 0.706 share of its stock for each share of Viasystems.

  • Auxilium Pharma rejects Endo's takeover offer Monday, 22 Sep 2014 | 7:45 AM ET

    CHESTERBROOK, Pa.— Auxilium Pharmaceuticals Inc.' s board has rejected an approximately $1.4 billion unsolicited takeover offer from Ireland's Endo International PLC. Auxilium, based in Chesterbrook, Pennsylvania, had adopted a one-year "poison pill" shareholder rights plan last week.

  • German Merck to buy St. Louis-based Sigma-Aldrich Monday, 22 Sep 2014 | 6:49 AM ET

    FRANKFURT, Germany— German drug company Merck says it has agreed to buy St. Louis- based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment.